The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract
Public ClinicalTrials.gov record NCT06365762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2, Randomized, Placebo-Controlled, Double-Masked, Multicenter, Dose-Ranging, Safety and Efficacy of C-KAD Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract
Study identification
- NCT ID
- NCT06365762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Livionex Inc.
- Industry
- Enrollment
- 111 participants
Conditions and interventions
Conditions
Interventions
- EDTA Ophthalmic Solution 1.3% Drug
- EDTA Ophthalmic Solution 2.6% Drug
- Saline Solution (Placebo) Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2005
- Primary completion
- Dec 30, 2006
- Completion
- Apr 29, 2007
- Last update posted
- Apr 15, 2024
2006 – 2007
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St Mary's Eye Specialists, Inc. | San Francisco | California | 94117 | — |
| Hunkeler Eye Institute | Overland Park | Kansas | 66210 | — |
| The Johns Hopkins Hospital & Health System, Wilmer Eye Institute | Lutherville | Maryland | 21093 | — |
| Harvard Medical School, Massachusetts Eye and Ear Infirmary | Boston | Massachusetts | 02114 | — |
| Charlotte Eye, Ear, Nose, and Throat Associates | Charlotte | North Carolina | 28210 | — |
| University of Utah, John Moran Eye Center | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06365762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 15, 2024 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06365762 live on ClinicalTrials.gov.